About Us

The Snowdome Foundation was formed in 2010 with a mission to accelerate new therapies for Australian blood cancer (myeloma, lymphoma and leukaemia) patients to help them live longer, better lives. It aims to accelerate access to new blood cancer treatments by channelling government and private philanthropic investments into ground breaking research, clinical trials, and personalised therapies. With the establishment of both the Centre of Research Excellence in Myeloma (CRE-M) and the Christine and Bruce Wilson Centre for Lymphoma Genomics, Snowdome Foundation has directed almost $12 million into the emerging field of genomics. Last year, Snowdome Foundation in collaboration with Maddie Riewoldt’s Vision received the inaugural National Charity award in the 2016 Telstra Australian Business Awards in recognition of their outstanding work.